PARP阻害剤バイオマーカーサービスの世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global PARP Inhibitor Biomarkers Service Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-02762 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、PARP阻害剤バイオマーカーサービスの世界市場を広く調査・分析し、今後の市場展望をまとめております。PARP阻害剤バイオマーカーサービスの種類別市場規模（BRCA 1＆2テスト、HRDテスト、HRRテスト、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Myriad Genetics, Inc.、NeoGenomics Laboratories, Inc.、Hoffmann-La Roche AG、Invitae Corporation、BPS Bioscience, Inc. ・地域別グローバル市場分析 2015年-2020年 ・PARP阻害剤バイオマーカーサービスの北米市場（アメリカ、カナダ、メキシコ） ・PARP阻害剤バイオマーカーサービスのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・PARP阻害剤バイオマーカーサービスのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・PARP阻害剤バイオマーカーサービスの南米市場（ブラジル、アルゼンチン） ・PARP阻害剤バイオマーカーサービスの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：BRCA 1＆2テスト、HRDテスト、HRRテスト、その他 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The PARP Inhibitor Biomarkers Service market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global PARP Inhibitor Biomarkers Service market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
PARP Inhibitor Biomarkers Service market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, PARP Inhibitor Biomarkers Service market has been segmented into:
BRCA 1 & 2 Testing
HRD Testing
HRR Testing
Others

By Application, PARP Inhibitor Biomarkers Service has been segmented into:
Hospital
Clinic
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global PARP Inhibitor Biomarkers Service market presented in the report. This section sheds light on the sales growth of different regional and country-level PARP Inhibitor Biomarkers Service markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global PARP Inhibitor Biomarkers Service market.

The report offers in-depth assessment of the growth and other aspects of the PARP Inhibitor Biomarkers Service market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and PARP Inhibitor Biomarkers Service Market Share Analysis
PARP Inhibitor Biomarkers Service competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, PARP Inhibitor Biomarkers Service sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the PARP Inhibitor Biomarkers Service sales, revenue and market share for each player covered in this report.

The major players covered in PARP Inhibitor Biomarkers Service are:
Myriad Genetics, Inc.
NeoGenomics Laboratories, Inc.
Hoffmann-La Roche AG
Invitae Corporation
BPS Bioscience, Inc.
Among other players domestic and global, PARP Inhibitor Biomarkers Service market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

---

1 PARP Inhibitor Biomarkers Service Market Overview
1.1 Product Overview and Scope of PARP Inhibitor Biomarkers Service
1.2 Classification of PARP Inhibitor Biomarkers Service by Type
1.2.1 Global PARP Inhibitor Biomarkers Service Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global PARP Inhibitor Biomarkers Service Revenue Market Share by Type in 2019
1.2.3 BRCA 1 & 2 Testing
1.2.4 HRD Testing
1.2.5 HRR Testing
1.2.6 Others
1.3 Global PARP Inhibitor Biomarkers Service Market by Application
1.3.1 Overview: Global PARP Inhibitor Biomarkers Service Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global PARP Inhibitor Biomarkers Service Market by Regions
1.4.1 Global PARP Inhibitor Biomarkers Service Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of PARP Inhibitor Biomarkers Service (2015-2025)
1.4.3 North America (USA, Canada and Mexico) PARP Inhibitor Biomarkers Service Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) PARP Inhibitor Biomarkers Service Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) PARP Inhibitor Biomarkers Service Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) PARP Inhibitor Biomarkers Service Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) PARP Inhibitor Biomarkers Service Status and Prospect (2015-2025)
2 Company Profiles
2.1 Myriad Genetics, Inc.
2.1.1 Myriad Genetics, Inc. Details
2.1.2 Myriad Genetics, Inc. Major Business
2.1.3 Myriad Genetics, Inc. SWOT Analysis
2.1.4 Myriad Genetics, Inc. Product and Services
2.1.5 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Revenue, Gross Margin and Market Share (2018-2019)
2.2 NeoGenomics Laboratories, Inc.
2.2.1 NeoGenomics Laboratories, Inc. Details
2.2.2 NeoGenomics Laboratories, Inc. Major Business
2.2.3 NeoGenomics Laboratories, Inc. SWOT Analysis
2.2.4 NeoGenomics Laboratories, Inc. Product and Services
2.2.5 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Revenue, Gross Margin and Market Share (2018-2019)
2.3 Hoffmann-La Roche AG
2.3.1 Hoffmann-La Roche AG Details
2.3.2 Hoffmann-La Roche AG Major Business
2.3.3 Hoffmann-La Roche AG SWOT Analysis
2.3.4 Hoffmann-La Roche AG Product and Services
2.3.5 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Revenue, Gross Margin and Market Share (2018-2019)
2.4 Invitae Corporation
2.4.1 Invitae Corporation Details
2.4.2 Invitae Corporation Major Business
2.4.3 Invitae Corporation SWOT Analysis
2.4.4 Invitae Corporation Product and Services
2.4.5 Invitae Corporation PARP Inhibitor Biomarkers Service Revenue, Gross Margin and Market Share (2018-2019)
2.5 BPS Bioscience, Inc.
2.5.1 BPS Bioscience, Inc. Details
2.5.2 BPS Bioscience, Inc. Major Business
2.5.3 BPS Bioscience, Inc. SWOT Analysis
2.5.4 BPS Bioscience, Inc. Product and Services
2.5.5 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global PARP Inhibitor Biomarkers Service Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 PARP Inhibitor Biomarkers Service Players Market Share
3.2.2 Top 10 PARP Inhibitor Biomarkers Service Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global PARP Inhibitor Biomarkers Service Revenue and Market Share by Regions
4.2 North America PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
4.3 Europe PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
4.5 South America PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
5 North America PARP Inhibitor Biomarkers Service Revenue by Countries
5.1 North America PARP Inhibitor Biomarkers Service Revenue by Countries (2015-2020)
5.2 USA PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
5.3 Canada PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
5.4 Mexico PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
6 Europe PARP Inhibitor Biomarkers Service Revenue by Countries
6.1 Europe PARP Inhibitor Biomarkers Service Revenue by Countries (2015-2020)
6.2 Germany PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
6.3 UK PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
6.4 France PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
6.5 Russia PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
6.6 Italy PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
7 Asia-Pacific PARP Inhibitor Biomarkers Service Revenue by Countries
7.1 Asia-Pacific PARP Inhibitor Biomarkers Service Revenue by Countries (2015-2020)
7.2 China PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
7.3 Japan PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
7.4 Korea PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
7.5 India PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
8 South America PARP Inhibitor Biomarkers Service Revenue by Countries
8.1 South America PARP Inhibitor Biomarkers Service Revenue by Countries (2015-2020)
8.2 Brazil PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
8.3 Argentina PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue PARP Inhibitor Biomarkers Service by Countries
9.1 Middle East & Africa PARP Inhibitor Biomarkers Service Revenue by Countries (2015-2020)
9.2 Saudi Arabia PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
9.3 UAE PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
9.4 Egypt PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
9.5 South Africa PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global PARP Inhibitor Biomarkers Service Revenue and Market Share by Type (2015-2020)
10.2 Global PARP Inhibitor Biomarkers Service Market Forecast by Type (2019-2024)
10.3 BRCA 1 & 2 Testing Revenue Growth Rate (2015-2025)
10.4 HRD Testing Revenue Growth Rate (2015-2025)
10.5 HRR Testing Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global PARP Inhibitor Biomarkers Service Market Segment by Application
11.1 Global PARP Inhibitor Biomarkers Service Revenue Market Share by Application (2015-2020)
11.2 PARP Inhibitor Biomarkers Service Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global PARP Inhibitor Biomarkers Service Market Size Forecast (2021-2025)
12.1 Global PARP Inhibitor Biomarkers Service Market Size Forecast (2021-2025)
12.2 Global PARP Inhibitor Biomarkers Service Market Forecast by Regions (2021-2025)
12.3 North America PARP Inhibitor Biomarkers Service Revenue Market Forecast (2021-2025)
12.4 Europe PARP Inhibitor Biomarkers Service Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific PARP Inhibitor Biomarkers Service Revenue Market Forecast (2021-2025)
12.6 South America PARP Inhibitor Biomarkers Service Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa PARP Inhibitor Biomarkers Service Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global PARP Inhibitor Biomarkers Service Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of PARP Inhibitor Biomarkers Service by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global PARP Inhibitor Biomarkers Service Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market PARP Inhibitor Biomarkers Service Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global PARP Inhibitor Biomarkers Service Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Myriad Genetics, Inc. Corporate Information, Location and Competitors
Table 7. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Major Business
Table 8. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Total Revenue (USD Million) (2017-2018)
Table 9. Myriad Genetics, Inc. SWOT Analysis
Table 10. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Product and Solutions
Table 11. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. NeoGenomics Laboratories, Inc. Corporate Information, Location and Competitors
Table 13. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Major Business
Table 14. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Total Revenue (USD Million) (2018-2019)
Table 15. NeoGenomics Laboratories, Inc. SWOT Analysis
Table 16. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Product and Solutions
Table 17. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Hoffmann-La Roche AG Corporate Information, Location and Competitors
Table 19. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Major Business
Table 20. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Total Revenue (USD Million) (2017-2018)
Table 21. Hoffmann-La Roche AG SWOT Analysis
Table 22. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Product and Solutions
Table 23. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Invitae Corporation Corporate Information, Location and Competitors
Table 25. Invitae Corporation PARP Inhibitor Biomarkers Service Major Business
Table 26. Invitae Corporation PARP Inhibitor Biomarkers Service Total Revenue (USD Million) (2017-2018)
Table 27. Invitae Corporation SWOT Analysis
Table 28. Invitae Corporation PARP Inhibitor Biomarkers Service Product and Solutions
Table 29. Invitae Corporation PARP Inhibitor Biomarkers Service Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. BPS Bioscience, Inc. Corporate Information, Location and Competitors
Table 31. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Major Business
Table 32. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Total Revenue (USD Million) (2017-2018)
Table 33. BPS Bioscience, Inc. SWOT Analysis
Table 34. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Product and Solutions
Table 35. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Global PARP Inhibitor Biomarkers Service Revenue (Million USD) by Players (2015-2020)
Table 37. Global PARP Inhibitor Biomarkers Service Revenue Share by Players (2015-2020)
Table 38. Global PARP Inhibitor Biomarkers Service Revenue (Million USD) by Regions (2015-2020)
Table 39. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Regions (2015-2020)
Table 40. North America PARP Inhibitor Biomarkers Service Revenue by Countries (2015-2020)
Table 41. North America PARP Inhibitor Biomarkers Service Revenue Market Share by Countries (2015-2020)
Table 42. Europe PARP Inhibitor Biomarkers Service Revenue (Million USD) by Countries (2015-2020)
Table 43. Asia-Pacific PARP Inhibitor Biomarkers Service Revenue (Million USD) by Countries (2015-2020)
Table 44. South America PARP Inhibitor Biomarkers Service Revenue by Countries (2015-2020)
Table 45. South America PARP Inhibitor Biomarkers Service Revenue Market Share by Countries (2015-2020)
Table 46. Middle East and Africa PARP Inhibitor Biomarkers Service Revenue (Million USD) by Countries (2015-2020)
Table 47. Middle East and Africa PARP Inhibitor Biomarkers Service Revenue Market Share by Countries (2015-2020)
Table 48. Global PARP Inhibitor Biomarkers Service Revenue (Million USD) by Type (2015-2020)
Table 49. Global PARP Inhibitor Biomarkers Service Revenue Share by Type (2015-2020)
Table 50. Global PARP Inhibitor Biomarkers Service Revenue Forecast by Type (2021-2025)
Table 51. Global PARP Inhibitor Biomarkers Service Revenue by Application (2015-2020)
Table 52. Global PARP Inhibitor Biomarkers Service Revenue Share by Application (2015-2020)
Table 53. Global PARP Inhibitor Biomarkers Service Revenue Forecast by Application (2021-2025)
Table 54. Global PARP Inhibitor Biomarkers Service Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. PARP Inhibitor Biomarkers Service Picture
Figure 2. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Type in 2019
Figure 3. BRCA 1 & 2 Testing Picture
Figure 4. HRD Testing Picture
Figure 5. HRR Testing Picture
Figure 6. Others Picture
Figure 7. PARP Inhibitor Biomarkers Service Revenue Market Share by Application in 2019
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Others Picture
Figure 11. Global PARP Inhibitor Biomarkers Service Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America PARP Inhibitor Biomarkers Service Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe PARP Inhibitor Biomarkers Service Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific PARP Inhibitor Biomarkers Service Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America PARP Inhibitor Biomarkers Service Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa PARP Inhibitor Biomarkers Service Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global PARP Inhibitor Biomarkers Service Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global PARP Inhibitor Biomarkers Service Revenue Share by Players in 2019
Figure 19. Global Top 5 Players PARP Inhibitor Biomarkers Service Revenue Market Share in 2019
Figure 20. Global Top 10 Players PARP Inhibitor Biomarkers Service Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global PARP Inhibitor Biomarkers Service Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Regions (2015-2020)
Figure 24. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Regions in 2018
Figure 25. North America PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 26. Europe PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 28. South America PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 30. North America PARP Inhibitor Biomarkers Service Revenue Market Share by Countries (2015-2020)
Figure 31. North America PARP Inhibitor Biomarkers Service Revenue Market Share by Countries in 2019
Figure 32. USA PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 33. Canada PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 34. Mexico PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 35. Europe PARP Inhibitor Biomarkers Service Revenue Market Share by Countries (2015-2020)
Figure 36. Europe PARP Inhibitor Biomarkers Service Revenue Market Share by Countries in 2019
Figure 37. Germany PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 38. UK PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 39. France PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 40. Russia PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 41. Italy PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific PARP Inhibitor Biomarkers Service Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific PARP Inhibitor Biomarkers Service Revenue Market Share by Countries in 2019
Figure 44. China PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 45. Japan PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 46. Korea PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 47. India PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 49. South America PARP Inhibitor Biomarkers Service Revenue Market Share by Countries (2015-2020)
Figure 50. South America PARP Inhibitor Biomarkers Service Revenue Market Share by Countries in 2019
Figure 51. Brazil PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 52. Argentina PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa PARP Inhibitor Biomarkers Service Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa PARP Inhibitor Biomarkers Service Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 56. UAE PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 57. Egypt PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 58. South Africa PARP Inhibitor Biomarkers Service Revenue and Growth Rate (2015-2020)
Figure 59. Global PARP Inhibitor Biomarkers Service Revenue Share by Type (2015-2020)
Figure 60. Global PARP Inhibitor Biomarkers Service Revenue Share by Type in 2019
Figure 61. Global PARP Inhibitor Biomarkers Service Market Share Forecast by Type (2021-2025)
Figure 62. Global BRCA 1 & 2 Testing Revenue Growth Rate (2015-2020)
Figure 63. Global HRD Testing Revenue Growth Rate (2015-2020)
Figure 64. Global HRR Testing Revenue Growth Rate (2015-2020)
Figure 65. Global Others Revenue Growth Rate (2015-2020)
Figure 66. Global PARP Inhibitor Biomarkers Service Revenue Share by Application (2015-2020)
Figure 67. Global PARP Inhibitor Biomarkers Service Revenue Share by Application in 2019
Figure 68. Global PARP Inhibitor Biomarkers Service Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospital Revenue Growth Rate (2015-2020)
Figure 70. Global Clinic Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global PARP Inhibitor Biomarkers Service Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global PARP Inhibitor Biomarkers Service Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global PARP Inhibitor Biomarkers Service Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America PARP Inhibitor Biomarkers Service Revenue Market Forecast (2021-2025)
Figure 76. Europe PARP Inhibitor Biomarkers Service Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific PARP Inhibitor Biomarkers Service Revenue Market Forecast (2021-2025)
Figure 78. South America PARP Inhibitor Biomarkers Service Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa PARP Inhibitor Biomarkers Service Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---